Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies.
about
Combinatorial library strategies for synthesis of cationic lipid-like nanoparticles and their potential medical applications.Physical Characterization of Gemini Surfactant-Based Synthetic Vectors for the Delivery of Linear Covalently Closed (LCC) DNA Ministrings.Gemini Surfactants Based on Bis-Imidazolium Alkoxy Derivatives as Effective Agents for Delivery of Nucleic Acids: A Structural and Spectroscopic StudyLysine-functionalized nanodiamonds: synthesis, physiochemical characterization, and nucleic acid binding studies.Impact of phospholipids on plasmid packaging and toxicity of gemini nanoparticles.Nanotechnology to drive stem cell commitment.Dicationic Surfactants with Glycine Counter Ions for Oligonucleotide Transportation.Interactions between DNA and Gemini surfactant: impact on gene therapy: part I.Polyamine-DNA interactions and development of gene delivery vehicles.α-Tocopherol derived lipid dimers as efficient gene transfection agents. Mechanistic insights into lipoplex internalization and therapeutic induction of apoptotic activity.Lipid encapsulation of cationic polymers in hybrid nanocarriers reduces their non-specific toxicity to breast epithelial cells.Novel pH-sensitive cationic lipids with linear ortho ester linkers for gene delivery.Serine-based gemini surfactants with different spacer linkages: from self-assembly to DNA compaction.High-performance method for specific effect on nucleic acids in cells using TiO2~DNA nanocomposites.Calcium carbonate microparticles used as a gene vector for delivering p53 gene into cancer cells.Functional study of dextran-graft-poly((2-dimethyl amino)ethyl methacrylate) gene delivery vector for tumor therapy.Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.Chimeric Adeno-Associated Virus-Mediated Cardiovascular Reprogramming for Ischemic Heart Disease.
P2860
Q35568750-C03B6357-B50F-46DF-B819-89C2EDC0351DQ35839684-4092DB8C-6AF4-4DDB-98A0-3559E9E68739Q35862401-C4A1B7E6-045B-418E-BA6D-71EEFB1AC0DBQ36161023-9B244349-5B86-4197-B5B3-A829FC356C41Q36362383-8C2A66E7-3BE1-40B4-A87C-95DF191586ABQ38087987-16818F1D-FAFF-47E6-915C-39BDE8BFA532Q38292373-F55B0CD2-D399-4764-866F-E4AB792DAA21Q38703014-58195CA8-1CFB-47AC-8B44-BC6F3A4EB06DQ38832002-A4B19319-10C3-4B9D-9F15-93A219F7806DQ38922635-C6AB14C1-4981-4DEA-A70E-EBB850A1178AQ39248020-15189B87-4E06-418A-8B3A-EE2FE6E49705Q39368753-7371C26D-EC51-48E4-A5FA-3BC311B00135Q41607169-4D0862D9-5CDF-4263-8823-3B4A6479338AQ42410857-37103BCC-B1D0-43E7-9039-BC1072AFA352Q45878723-0FFCEABE-19E2-4A3D-84BB-5F20A9C3BFDDQ45879282-7E8D54D7-3AE1-498D-9A75-ACEF99B02DFBQ50070105-0D3B9875-6322-41AE-A9E6-6BF7AA3AB7ECQ55691385-6F40B713-C8D5-407B-B4C3-4717DC07DD6B
P2860
Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advancing nonviral gene delive ...... anoparticle design strategies.
@en
Advancing nonviral gene delive ...... anoparticle design strategies.
@nl
type
label
Advancing nonviral gene delive ...... anoparticle design strategies.
@en
Advancing nonviral gene delive ...... anoparticle design strategies.
@nl
prefLabel
Advancing nonviral gene delive ...... anoparticle design strategies.
@en
Advancing nonviral gene delive ...... anoparticle design strategies.
@nl
P2093
P2860
P356
P1433
P1476
Advancing nonviral gene delive ...... anoparticle design strategies.
@en
P2093
Ildiko Badea
Mahmoud Elsabahy
Marianna Foldvari
McDonald Donkuru
Ronald Verrall
Shawn Wettig
P2860
P304
P356
10.2217/NNM.10.80
P577
2010-09-01T00:00:00Z